## **Core Concept**
The management of increased intracranial pressure (ICP) in the setting of head injury without a hematoma involves reducing ICP to prevent further brain injury. This is typically achieved through measures that decrease cerebral edema, reduce cerebral blood volume, or improve cerebral venous drainage.

## **Why the Correct Answer is Right**
Mannitol, an osmotic diuretic, is often used as a first-line agent to manage elevated ICP. It works by creating an osmotic gradient that draws water out of brain cells, thereby reducing cerebral edema. Additionally, mannitol can help reduce blood viscosity, which may improve cerebral blood flow. Its effect on reducing ICP is rapid, making it suitable for acute management.

## **Why Each Wrong Option is Incorrect**
* **Option A:** Though not specified, if this option refers to another agent not typically used for acute ICP management, it would be incorrect because mannitol and hypertonic saline are the primary agents used in this setting.
* **Option B:** If this option refers to a corticosteroid, it would be incorrect because corticosteroids have no immediate effect on reducing ICP and are not used for acute management of elevated ICP.
* **Option D:** If this option refers to a different agent not commonly used for initial ICP management, such as a barbiturate, it would be incorrect because while barbiturates can reduce ICP, they are typically considered for refractory cases due to their side effects and the need for close monitoring.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that mannitol's effectiveness in reducing ICP can be assessed by monitoring urine output and serum osmolality. A clinical pearl is that the use of mannitol may not be beneficial if serum osmolality exceeds 320 mOsm/L, as it may not effectively cross the blood-brain barrier.

## **Correct Answer:** .